This startup saves lives. Meet Indonesia's Etana! They create high-quality, affordable, innovative biopharmaceutical products for major health conditions.

• They focus on cancer and vaccine-related products.
  

They've just raised new funding! While they didn't release the amount or funding round, here's what you should know about Etana.

• Say what? Biopharmaceuticals are therapies, vaccines, and drugs made through biotech processes or from biological sources like living cells and proteins.
• They were the first biopharma company in ASEAN to have mRNA vaccine technology.
  

Investor check. DEG led the round. Yunfeng Capital, HighLight Capital, and East Ventures also joined in! 

• They last raised a Series B in late 2022.

‍

🏥 Why it matters

COVID showed us how inadequate our local healthcare systems are and how important it is to build the capacity to create, innovate and produce local healthcare products like vaccines. We need to localize healthcare innovation!

• Products like Etana's will help strengthen the national healthcare system.
  

‍

👇🏼 The ABCs on Etana

Founded in 2014, they research, produce, and market biopharma products focused on the SEA market!

• Produced locally. They have state-of-the-art production facilities in Indonesia, all meeting the international FDA and local Indonesian Food and Drug Authority (BPOM) standards.
• And localized! They're certified by the Indonesian Ulema Council (MUI) to produce halal-certified products. (FYI, halal certification was an issue with COVID vaccines!)

‍

🤩 The goal?

Be a leading biopharmaceutical company in ASEAN by aggressively expanding their production and doubling down on their product development.

• They're currently focused on researching and producing mRNA platforms, proteins, and monoclonal antibodies.
• They're building up production to support Indonesian government programs, meet local domestic market needs, and for exportation to the ASEAN market and other countries!
  

‍

💉 Already in the pipeline

They're already producing their own halal-certified mRNA COVID vaccine. 

• Oh, and the Indonesian president gave them a hat-tip.
  

They've also got other products in the pipeline, like BEVAGEN, a life-saving cancer drug for lung and metastatic colorectal cancer, and Erythropoietin for dialysis treatment.

• They're also looking to develop an adenovirus (aka, cold and flu-like illnesses) platform for vaccine production.

‍

💰 What's with the $$$?

They'll be strengthening their pipeline and portfolio, especially for cancer-related products. They'll also be improving their production capacity for biopharma productions, in line with policies promoted by Indonesia's government.

‍